Concepedia

Xueqing Lu

XL

Statistics

Publications

6

Citations

100

H-Index

6

Active since

2003

Affiliations

Antigen Express (United States)(Current)

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Harper University Hospital

Xueqing Lu is an author at Antigen Express (United States) specializing in tumor immunology, immunology, and mhc class ii molecules.

Publications per year

2003–2005

6

Publications

6

Enhanced CD4+ T-Cell Response in DR4-Transgenic Mice to a Hybrid Peptide Linking the Ii-Key Segment of the Invariant Chain to the Melanoma gp100(48-58) MHC Class II Epitope

Nikoletta L. Kallinteris, Shuzhen Wu, Xueqing Lu et al. · Journal of Immunotherapy · 2005 · 22 citations

, , +17

Tumor immunotherapy by converting tumor cells to MHC class II?positive, Ii protein?negative phenotype

Xueqing Lu, Nikoletta L. Kallinteris, Jizhi Li et al. · Cancer Immunology Immunotherapy · 2003 · 21 citations · Full text

, , +17

Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells

Gilda G. Hillman, Nikoletta L. Kallinteris, J Li et al. · Gene Therapy · 2003 · 18 citations

, , +17

Radiation Improves Intratumoral Gene Therapy for Induction of Cancer Vaccine in Murine Prostate Carcinoma

Gilda G. Hillman, Minzhen Xu, Yu Wang et al. · Human Gene Therapy · 2003 · 15 citations · Full text

, , +17

Curative Antitumor Immune Response Is Optimal with Tumor Irradiation Followed by Genetic Induction of Major Histocompatibility Complex Class I and Class II Molecules and Suppression of Ii Protein

Yu Wang, Minzhen Xu, Mingxin Che et al. · Human Gene Therapy · 2005 · 14 citations · Full text

, , +17

1–5 of 6